Junshi Biosciences Announces 2025 Full Year Financial Results and Provides Corporate Updates

Junshi Biosciences Announces Strategic Collaboration with Antengene to Evaluate Combination Therapy with JS207 (PD-1/VEGF…
Scroll to Top